- Home
- SUPN vs TRMD Comparison
SUPN vs TRMD Comparison
Compare SUPN & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- TRMD
- Stock Information
- Founded
- SUPN 2005
- TRMD 1889
- Country
- SUPN United States
- TRMD United Kingdom
- Employees
- SUPN N/A
- TRMD N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- TRMD Marine Transportation
- Sector
- SUPN Health Care
- TRMD Consumer Discretionary
- Exchange
- SUPN Nasdaq
- TRMD Nasdaq
- Market Cap
- SUPN 2.0B
- TRMD 1.9B
- IPO Year
- SUPN 2012
- TRMD N/A
- Fundamental
- Price
- SUPN $36.45
- TRMD $18.58
- Analyst Decision
- SUPN Hold
- TRMD Buy
- Analyst Count
- SUPN 1
- TRMD 1
- Target Price
- SUPN $36.00
- TRMD $48.00
- AVG Volume (30 Days)
- SUPN 285.1K
- TRMD 1.3M
- Earning Date
- SUPN 11-04-2024
- TRMD 11-07-2024
- Dividend Yield
- SUPN N/A
- TRMD 26.39%
- EPS Growth
- SUPN 130.79
- TRMD N/A
- EPS
- SUPN 1.07
- TRMD 7.70
- Revenue
- SUPN $651,972,000.00
- TRMD $1,641,593,000.00
- Revenue This Year
- SUPN $7.82
- TRMD N/A
- Revenue Next Year
- SUPN N/A
- TRMD N/A
- P/E Ratio
- SUPN $34.11
- TRMD $2.54
- Revenue Growth
- SUPN 6.79
- TRMD 3.90
- 52 Week Low
- SUPN $25.53
- TRMD $18.01
- 52 Week High
- SUPN $39.37
- TRMD $40.47
- Technical
- Relative Strength Index (RSI)
- SUPN 48.87
- TRMD 26.36
- Support Level
- SUPN $35.68
- TRMD $18.01
- Resistance Level
- SUPN $37.35
- TRMD $19.48
- Average True Range (ATR)
- SUPN 1.01
- TRMD 0.54
- MACD
- SUPN -0.18
- TRMD 0.08
- Stochastic Oscillator
- SUPN 21.65
- TRMD 14.73
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Exhaust segment.